AMDA's 2019 Annual Conference

SA13 - Operationalizing Frailty: The Next Frontier in PALTC (A Concise Review of Practical Frailty Measurement Tools)

Mar 9, 2019 2:30pm ‐ Mar 9, 2019 3:30pm


This session, led by an AMDA innovation award winner, will discuss the current understanding of frailty and present an overview of the science behind frailty measurement. The impact of frailty on quality and value-based reimbursement will be presented, with emphasis on communication of risk for poor outcomes, often unavoidable, with families. PALTC operators are increasingly squeezed between decreasing reimbursements and increasing costs of care while clinical practice models have not changed in decades. Part of the challenge stems from a lack of risk assessment and evidence-based management tools for the most clinically vulnerable and costliest patient population. As recent The Centers for Medicare & Medicaid Services changes create pressures to move away from a volume-based model to a quality and value-based model, facilities are seeing fewer traditional post-operative rehabilitation patients and instead are facing an increased prevalence in the medically complex and frail. Presenters will address these facility pain-points and present several case studies where frailty assessment helped impact outcomes and set patient/family expectations. Knowing the degree of vulnerability to adverse outcomes at the time of admission allows for necessary preparations to be made upon admission and helps clinicians address the incongruity between risks and expectations. After admission, the minimum data set (MDS) data can be reliably used to trend frailty as an indicator of change in condition. Case studies will be presented by subject matter experts, including two geriatricians who are active medical directors and a geriatric nurse practitioner with over 25 years of frailty experience.

Learning Objectives: 

  • Describe the impact of vulnerability from frailty as it applies to quality and value.
  • Review evidence-based literature behind practical frailty tools.
  • Measure the potential value of calculating frailty from facilities’ MDS data and its impact on quality outcome measures, rehospitalization, and reimbursement.
  • Recognize the potential for better clinical outcomes when frailty based risk informs approaches to care.


You must be logged in and own this session in order to post comments.